Aap Implantate AG Announces Annual General Meeting for January 2025

aap Implantate AG has announced that its Annual General Meeting will occur on January 15, 2025, at the company's headquarters in Berlin. During this meeting, the Management and Supervisory Boards will present the 2023 financial year’s adopted and consolidated financial statements. A resolution regarding the discharge of both boards will also be proposed.

Additionally, the Supervisory Board intends to propose the election of a new auditor for 2024, a move partially influenced by the previous auditor stepping down. This meeting will also review the audited remuneration report for 2023. The presentation will facilitate a uniform dividend for all current shares, which will enable the company to list previously unlisted shares on the regulated market under ISIN: DE000A3H2101, potentially increasing share liquidity.